Morgan Stanley Reiterates Equal Weight Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Morgan Stanley reissued their equal weight rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research report sent to investors on Monday, Marketbeat reports. Several other brokerages also recently issued reports on SRPT. BMO Capital Markets downgraded shares of Sarepta Therapeutics from an “outperform” rating to a “market perform” rating and cut […]
Morgan Stanley reissued their equal weight rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research report sent to investors on Monday, Marketbeat reports. Several other brokerages also recently issued reports on SRPT. BMO Capital Markets downgraded shares of Sarepta Therapeutics from an “outperform” rating to a “market perform” rating and cut […]
